Trinder D, Stephenson J M, Gao X, Phillips P A, Risvanis J, Johnston C I
University of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.
Peptides. 1991 Nov-Dec;12(6):1195-200. doi: 10.1016/0196-9781(91)90194-t.
Binding characteristics of the selective V2 antagonist radioligand [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP to rat kidney were determined. Binding was specific, saturable and reversible. The peptide bound to a single class of high-affinity binding sites with Bmax 69.4 +/- 6.8 fmol/mg protein and KD 2.8 +/- 0.3 nM. AVP and other related peptides displaced [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP binding. The order of potency of inhibition was desamino-D-AVP greater than AVP greater than d(CH2)5[D-Ileu2,Ileu4]AVP greater than oxytocin greater than d(CH2)5[Tyr(Me)2]AVP greater than d(CH2)5[sarcosine7]AVP, which is typical of a selective V2 radioligand. Autoradiographic localization of [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP binding sites in kidney showed dense binding in the inner and outer medulla with less binding in the cortex, which is consistent with known renal V2 receptor distribution.
测定了选择性V2拮抗剂放射性配体[3H]去甘氨酰胺(9)-d(CH2)5[D-异亮氨酸2,异亮氨酸4]抗利尿激素(AVP)与大鼠肾脏的结合特性。结合是特异性的、可饱和的且可逆的。该肽与一类单一的高亲和力结合位点结合,Bmax为69.4±6.8 fmol/mg蛋白质,KD为2.8±0.3 nM。AVP和其他相关肽可取代[3H]去甘氨酰胺(9)-d(CH2)5[D-异亮氨酸2,异亮氨酸4]AVP的结合。抑制效力顺序为去氨基-D-AVP>AVP>d(CH2)5[D-异亮氨酸2,异亮氨酸4]AVP>催产素>d(CH2)5[酪氨酸(甲基)2]AVP>d(CH2)5[肌氨酸7]AVP,这是选择性V2放射性配体的典型特征。肾脏中[3H]去甘氨酰胺(9)-d(CH2)5[D-异亮氨酸2,异亮氨酸4]AVP结合位点的放射自显影定位显示,内髓和外髓结合密集,皮质结合较少,这与已知的肾脏V2受体分布一致。